Overview
Blachy Davila is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Davila is rated as an Advanced provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Hemophagocytic Lymphohistiocytosis, Graft Versus Host Disease (GvHD), Virus Associated Hemophagocytic Syndrome, and Bone Marrow Transplant.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of X-Linked Severe Combined Immunodeficiency.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
111 Michigan Ave NW, Washington, DC 20010
Additional Areas of Focus
Dr. Davila has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Park Medical Associates LLC
Eric Seifter is an Oncologist in Lutherville, Maryland. Dr. Seifter is rated as an Advanced provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).
Children's National Hospital
David Jacobsohn is a Hematologist and an Oncologist in Silver Spring, Maryland. Dr. Jacobsohn is rated as a Distinguished provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. His top areas of expertise are Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant.
MedStar Georgetown University Hospital
Corina Gonzalez is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. Her top areas of expertise are Graft Versus Host Disease (GvHD), Severe Combined Immunodeficiency (SCID), Chronic Graft Versus Host Disease (cGvHD), X-Linked Severe Combined Immunodeficiency, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Severe Combined Immunodeficiency (SCID)Dr. Davila isDistinguished. Learn about Severe Combined Immunodeficiency (SCID).
- Advanced
- Graft Versus Host Disease (GvHD)Dr. Davila isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Hemophagocytic Lymphohistiocytosis
- Virus Associated Hemophagocytic Syndrome
- X-Linked Severe Combined Immunodeficiency
- Experienced
- Aase SyndromeDr. Davila isExperienced. Learn about Aase Syndrome.
- Acute Lymphoblastic Leukemia (ALL)Dr. Davila isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Aplastic AnemiaDr. Davila isExperienced. Learn about Aplastic Anemia.
- Blood ClotsDr. Davila isExperienced. Learn about Blood Clots.
- Bone Marrow TransplantDr. Davila isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)